Met Life Investment Management, LLC Gilead Sciences, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 323,789 shares of GILD stock, worth $31.9 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
323,789
Previous 332,350 2.58%
Holding current value
$31.9 Million
Previous $22.8 Million 19.02%
% of portfolio
0.16%
Previous 0.14%

Shares

79 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $570,076 - $719,038
-8,561 Reduced 2.58%
323,789 $27.1 Million
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $2.56 Million - $2.95 Million
40,522 Added 13.89%
332,350 $22.8 Million
Q1 2024

May 14, 2024
BUY
$71.58 - $87.29 $20.9 Million - $25.5 Million
291,828 New
291,828 $21.4 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $418,664 - $474,776
-5,714 Reduced 1.85%
302,565 $24.5 Million
Q3 2023

May 09, 2024
SELL
$73.94 - $80.67 $1.01 Million - $1.11 Million
-13,719 Reduced 4.26%
308,279 $23.1 Million
Q3 2023

Apr 29, 2024
SELL
$73.94 - $80.67 $619,321 - $675,691
-8,376 Reduced 2.65%
308,279 $23.1 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $619,321 - $675,691
-8,376 Reduced 2.65%
308,279 $23.1 Million
Q2 2023

Apr 29, 2024
BUY
$76.01 - $86.7 $24.1 Million - $27.5 Million
316,655 New
316,655 $24.4 Million
Q2 2023

Aug 10, 2023
SELL
$76.01 - $86.7 $406,121 - $463,238
-5,343 Reduced 1.66%
316,655 $24.4 Million
Q1 2023

May 09, 2024
BUY
$77.31 - $88.08 $24.9 Million - $28.4 Million
321,998 New
321,998 $26.7 Billion
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $432,704 - $492,983
-5,597 Reduced 1.71%
321,998 $26.7 Million
Q4 2022

May 10, 2024
SELL
$62.32 - $89.47 $320,698 - $460,412
-5,146 Reduced 1.55%
327,595 $28.1 Million
Q4 2022

Jun 14, 2023
BUY
$62.32 - $89.47 $348,805 - $500,763
5,597 Added 1.74%
327,595 $28.1 Million
Q4 2022

Mar 22, 2023
SELL
$62.32 - $89.47 $320,698 - $460,412
-5,146 Reduced 1.55%
327,595 $28.1 Million
Q4 2022

Feb 15, 2023
SELL
$62.32 - $89.47 $320,698 - $460,412
-5,146 Reduced 1.55%
327,595 $28.1 Million
Q3 2022

May 10, 2024
SELL
$59.54 - $68.01 $309,488 - $353,515
-5,198 Reduced 1.54%
332,741 $20.5 Million
Q3 2022

Jun 14, 2023
BUY
$59.54 - $68.01 $639,638 - $730,631
10,743 Added 3.34%
332,741 $20.5 Million
Q3 2022

Mar 22, 2023
SELL
$59.54 - $68.01 $309,488 - $353,515
-5,198 Reduced 1.54%
332,741 $20.5 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $309,488 - $353,515
-5,198 Reduced 1.54%
332,741 $20.5 Million
Q2 2022

May 10, 2024
SELL
$57.72 - $65.01 $196,363 - $221,164
-3,402 Reduced 1.0%
337,939 $20.9 Million
Q2 2022

Jun 20, 2023
BUY
$57.72 - $65.01 $920,114 - $1.04 Million
15,941 Added 4.95%
337,939 $20.9 Million
Q2 2022

Mar 22, 2023
SELL
$57.72 - $65.01 $196,363 - $221,164
-3,402 Reduced 1.0%
337,939 $20.9 Million
Q2 2022

Aug 11, 2022
SELL
$57.72 - $65.01 $196,363 - $221,164
-3,402 Reduced 1.0%
337,939 $20.9 Million
Q1 2022

May 10, 2024
BUY
$57.92 - $72.58 $19.8 Million - $24.8 Million
341,341 New
341,341 $20.3 Million
Q1 2022

Jun 20, 2023
BUY
$57.92 - $72.58 $1.12 Million - $1.4 Million
19,343 Added 6.01%
341,341 $20.3 Million
Q1 2022

Mar 22, 2023
BUY
$57.92 - $72.58 $3.72 Million - $4.66 Million
64,195 Added 23.16%
341,341 $20.3 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $3.72 Million - $4.66 Million
64,195 Added 23.16%
341,341 $20.3 Million
Q4 2021

May 17, 2024
SELL
$64.88 - $73.64 $391,875 - $444,785
-6,040 Reduced 2.13%
277,146 $20.1 Million
Q4 2021

Jun 21, 2023
SELL
$64.88 - $73.64 $2.91 Million - $3.3 Million
-44,852 Reduced 13.93%
277,146 $20.1 Million
Q4 2021

Mar 22, 2023
SELL
$64.88 - $73.64 $2.01 Million - $2.29 Million
-31,039 Reduced 10.07%
277,146 $20.1 Million
Q4 2021

Feb 15, 2022
SELL
$64.88 - $73.64 $2.01 Million - $2.29 Million
-31,039 Reduced 10.07%
277,146 $20.1 Million
Q3 2021

May 17, 2024
SELL
$67.69 - $73.03 $513,699 - $554,224
-7,589 Reduced 2.61%
283,186 $19.8 Million
Q3 2021

Jun 21, 2023
SELL
$67.69 - $73.03 $2.63 Million - $2.83 Million
-38,812 Reduced 12.05%
283,186 $19.8 Million
Q3 2021

Mar 22, 2023
BUY
$67.69 - $73.03 $1.18 Million - $1.27 Million
17,410 Added 5.99%
308,185 $21.5 Million
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $1.18 Million - $1.27 Million
17,410 Added 5.99%
308,185 $21.5 Million
Q2 2021

May 17, 2024
SELL
$63.47 - $69.35 $550,284 - $601,264
-8,670 Reduced 2.9%
290,775 $20 Million
Q2 2021

Jun 21, 2023
SELL
$63.47 - $69.35 $1.98 Million - $2.17 Million
-31,223 Reduced 9.7%
290,775 $20 Million
Q2 2021

Mar 22, 2023
SELL
$63.47 - $69.35 $2.17 Million - $2.37 Million
-34,153 Reduced 10.51%
290,775 $20 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $2.17 Million - $2.37 Million
-34,153 Reduced 10.51%
290,775 $20 Million
Q1 2021

May 17, 2024
BUY
$60.0 - $68.46 $457,020 - $521,459
7,617 Added 2.61%
299,445 $19.4 Million
Q1 2021

Jun 26, 2023
SELL
$60.0 - $68.46 $1.35 Million - $1.54 Million
-22,553 Reduced 7.0%
299,445 $19.4 Billion
Q1 2021

Mar 22, 2023
BUY
$60.0 - $68.46 $1.23 Million - $1.4 Million
20,502 Added 6.73%
324,928 $21 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $1.23 Million - $1.4 Million
20,502 Added 6.73%
324,928 $21 Million
Q4 2020

May 24, 2024
SELL
$56.65 - $64.55 $761,772 - $868,003
-13,447 Reduced 4.23%
304,426 $17.7 Million
Q4 2020

Jun 22, 2023
SELL
$56.65 - $64.55 $995,453 - $1.13 Million
-17,572 Reduced 5.46%
304,426 $17.7 Million
Q4 2020

Mar 22, 2023
SELL
$56.65 - $64.55 $761,772 - $868,003
-13,447 Reduced 4.23%
304,426 $17.7 Million
Q4 2020

Feb 16, 2021
SELL
$56.65 - $64.55 $761,772 - $868,003
-13,447 Reduced 4.23%
304,426 $17.7 Million
Q3 2020

May 24, 2024
SELL
$62.1 - $78.08 $626,837 - $788,139
-10,094 Reduced 3.08%
317,873 $20.1 Billion
Q3 2020

Jun 26, 2023
SELL
$62.1 - $78.08 $256,162 - $322,080
-4,125 Reduced 1.28%
317,873 $20.1 Million
Q3 2020

Mar 22, 2023
SELL
$62.1 - $78.08 $626,837 - $788,139
-10,094 Reduced 3.08%
317,873 $20.1 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $626,837 - $788,139
-10,094 Reduced 3.08%
317,873 $20.1 Million
Q2 2020

May 24, 2024
BUY
$72.34 - $84.0 $2.61 Million - $3.04 Million
36,139 Added 12.38%
327,967 $25.2 Billion
Q2 2020

Jun 26, 2023
BUY
$72.34 - $84.0 $431,797 - $501,396
5,969 Added 1.85%
327,967 $25.2 Million
Q2 2020

Mar 22, 2023
BUY
$72.34 - $84.0 $134,552 - $156,240
1,860 Added 0.57%
327,967 $25.2 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $134,552 - $156,240
1,860 Added 0.57%
327,967 $25.2 Million
Q1 2020

Jul 12, 2023
BUY
$62.63 - $80.22 $257,346 - $329,623
4,109 Added 1.28%
326,107 $24.4 Million
Q1 2020

Mar 22, 2023
SELL
$62.63 - $80.22 $624,922 - $800,435
-9,978 Reduced 2.97%
326,107 $24.4 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $624,922 - $800,435
-9,978 Reduced 2.97%
326,107 $24.4 Million
Q4 2019

Jul 12, 2023
BUY
$61.62 - $67.78 $868,040 - $954,816
14,087 Added 4.37%
336,085 $21.8 Million
Q4 2019

Mar 22, 2023
SELL
$61.62 - $67.78 $527,652 - $580,400
-8,563 Reduced 2.48%
336,085 $21.8 Million
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $527,652 - $580,400
-8,563 Reduced 2.48%
336,085 $21.8 Million
Q3 2019

Jul 12, 2023
BUY
$62.51 - $69.0 $1.42 Million - $1.56 Million
22,650 Added 7.03%
344,648 $21.8 Million
Q3 2019

Mar 22, 2023
SELL
$62.51 - $69.0 $365,183 - $403,098
-5,842 Reduced 1.67%
344,648 $21.8 Million
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $365,183 - $403,098
-5,842 Reduced 1.67%
344,648 $21.8 Million
Q2 2019

Jul 12, 2023
BUY
$61.87 - $69.38 $1.76 Million - $1.98 Million
28,492 Added 8.85%
350,490 $23.7 Million
Q2 2019

Mar 22, 2023
SELL
$61.87 - $69.38 $748,008 - $838,804
-12,090 Reduced 3.33%
350,490 $23.7 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $748,008 - $838,804
-12,090 Reduced 3.33%
350,490 $23.7 Million
Q1 2019

Jul 13, 2023
BUY
$62.53 - $70.05 $2.54 Million - $2.84 Million
40,582 Added 12.6%
362,580 $23.6 Million
Q1 2019

Mar 22, 2023
SELL
$62.53 - $70.05 $461,033 - $516,478
-7,373 Reduced 1.99%
362,580 $23.6 Million
Q1 2019

May 15, 2019
SELL
$62.53 - $70.05 $461,033 - $516,478
-7,373 Reduced 1.99%
362,580 $23.6 Million
Q4 2018

Jul 13, 2023
BUY
$60.54 - $79.0 $2.9 Million - $3.79 Million
47,955 Added 14.89%
369,953 $23.1 Million
Q4 2018

Mar 22, 2023
SELL
$60.54 - $79.0 $433,284 - $565,403
-7,157 Reduced 1.9%
369,953 $23.1 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $433,284 - $565,403
-7,157 Reduced 1.9%
369,953 $23.1 Million
Q3 2018

Jul 13, 2023
BUY
$71.28 - $78.92 $3.93 Million - $4.35 Million
55,112 Added 17.12%
377,110 $29.1 Million
Q3 2018

Mar 22, 2023
BUY
$71.28 - $78.92 $3.53 Million - $3.91 Million
49,515 Added 15.11%
377,110 $29.1 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $403,230 - $446,450
-5,657 Reduced 1.48%
377,110 $29.1 Million
Q2 2018

Aug 15, 2018
SELL
$64.88 - $75.68 $743,070 - $866,763
-11,453 Reduced 2.91%
382,767 $27.1 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $724,758 - $883,560
-9,950 Reduced 2.46%
394,220 $29.7 Million
Q4 2017

Feb 15, 2018
BUY
$71.15 - $83.52 $28.8 Million - $33.8 Million
404,170
404,170 $29 Million

Others Institutions Holding GILD

# of Institutions
1,962
Shares Held
995M
Call Options Held
10.5M
Put Options Held
9.85M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email